10/17/2024 3:54 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 15-12G | |
10/04/2024 3:21 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:24 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:27 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:30 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:33 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:36 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:18 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:16 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form POSASR | |
08/27/2024 9:14 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
Get the Latest News and Ratings for MOR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter.
|
08/13/2024 3:31 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/07/2024 3:51 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9/A | |
08/07/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/05/2024 7:14 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/02/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/01/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/31/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/30/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/29/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024 3:05 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 25 Notification of the removal from listing and registration of matured, redeemed or retired securities | |
07/18/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/18/2024 10:25 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2024 3:20 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/05/2024 5:48 AM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9 | |
07/05/2024 5:02 AM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T | |
07/02/2024 9:18 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/21/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/21/2024 9:07 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024 3:41 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024 3:33 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC14D9C | |
06/20/2024 2:38 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-C | |
06/17/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024 11:06 AM | GOLDMAN SACHS GROUP INC (Filed by) GOLDMAN SACHS GROUP INC (Filed by) MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 13G/A | |
06/10/2024 10:01 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2024 3:36 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/05/2024 9:22 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
Did you know you can now trade Bitcoin in your regular brokerage account? (Ad) We’re on the edge of what could be a massive parabolic move in Bitcoin that pushes the price past all-time highs… and over $100K.
There was a little-known move by the NYSE in late 2021 that opened up a “loophole” for anyone with a regular brokerage account to take advantage of Bitcoin.
Combined with a Trump presidency—who says he wants to be known as the first “Crypto President”—this creates an unprecedented opportunity.
 You’ll want to see the explosive opportunity that looks ready to surge in the days and weeks ahead |
06/04/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |